Pericardial Cavity

  • 3E0Y3 - Percutaneous
    • 3E0Y30
      • 3E0Y304 - Introduction Pericardial Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
      • 3E0Y305 - Introduction Pericardial Cavity to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0Y30M - Introduction Pericardial Cavity to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
    • 3E0Y32
      • 3E0Y328 - Introduction Pericardial Cavity to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E0Y329 - Introduction Pericardial Cavity to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0Y33
      • 3E0Y33Z - Introduction Pericardial Cavity to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0Y36
      • 3E0Y36Z - Introduction Pericardial Cavity to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0Y37
      • 3E0Y37Z - Introduction Pericardial Cavity to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E0Y3B
      • 3E0Y3BZ - Introduction Pericardial Cavity to No Qualifier with Anesthetic Agent, Percutaneous Approach
    • 3E0Y3G
      • 3E0Y3GC - Introduction Pericardial Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Approach
    • 3E0Y3H
      • 3E0Y3HZ - Introduction Pericardial Cavity to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E0Y3K
      • 3E0Y3KZ - Introduction Pericardial Cavity to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E0Y3N
      • 3E0Y3NZ - Introduction Pericardial Cavity to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E0Y3S
      • 3E0Y3SF - Introduction Pericardial Cavity to Other Gas with Gas, Percutaneous Approach
    • 3E0Y3T
      • 3E0Y3TZ - Introduction Pericardial Cavity to No Qualifier with Destructive Agent, Percutaneous Approach
  • 3E0Y4 - Percutaneous Endoscopic
    • 3E0Y4G
      • 3E0Y4GC - Introduction Pericardial Cavity to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
  • 3E0Y7 - Via Natural or Artificial Opening
    • 3E0Y70
      • 3E0Y704 - Introduction Pericardial Cavity to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0Y705 - Introduction Pericardial Cavity to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0Y70M - Introduction Pericardial Cavity to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach
    • 3E0Y7S
      • 3E0Y7SF - Introduction Pericardial Cavity to Other Gas with Gas, Via Natural or Artificial Opening Approach